{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06410924",
            "orgStudyIdInfo": {
                "id": "DD01-DN-02"
            },
            "organization": {
                "fullName": "Neuraly, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH",
            "officialTitle": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Treatment With DD01 for 48 Weeks in Overweight/Obese Subjects With MASLD/MASH",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-in-overweight-obese-subjects-with-masld-mash"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-08",
            "studyFirstSubmitQcDate": "2024-05-08",
            "studyFirstPostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Neuraly, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 2 Study to evaluate the effect of DD01 treatment in overweight/obese patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH)."
        },
        "conditionsModule": {
            "conditions": [
                "NAFLD",
                "NASH"
            ],
            "keywords": [
                "Liver Disease",
                "Fatty Liver",
                "Non-alcoholic fatty liver disease",
                "Non-alcoholic steatohepatitis",
                "MASH",
                "MASLD"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 68,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "DD01",
                    "type": "EXPERIMENTAL",
                    "description": "Study Drug",
                    "interventionNames": [
                        "Drug: DD01"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Matching Placebo",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "DD01",
                    "description": "Dual GLP-1 and glucagon receptor agonist",
                    "armGroupLabels": [
                        "DD01"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo matching DD01",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of subjects who achieve at least 30% liver fat reduction measured by MRI-PDFF",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Absolute change in percent liver fat content as assessed by MRI-PDFF",
                    "timeFrame": "12 weeks and 48 weeks"
                },
                {
                    "measure": "Change in liver stiffness as assessed by Magnetic Resonance Elastography (MRE)",
                    "timeFrame": "12 weeks and 48 weeks"
                },
                {
                    "measure": "Change in liver stiffness measurements as assessed by FibroScan",
                    "timeFrame": "12 weeks and 48 weeks"
                },
                {
                    "measure": "Change in liver steatosis as assessed by FibroScan",
                    "timeFrame": "12 weeks and 48 weeks"
                },
                {
                    "measure": "Number of participants with Adverse Events",
                    "timeFrame": "12 and 48 weeks"
                },
                {
                    "measure": "Change in liver biochemistry",
                    "description": "To determine the effect in liver biochemistry parameters including ALT, AST, AST/ALT ration, Gamma-glutamyl transferase, bilirubin",
                    "timeFrame": "12 and 48 weeks"
                },
                {
                    "measure": "Change in glucose metabolism parameters",
                    "description": "To determine the effect on glucose metabolism parameters including glucose, insulin, C-peptide and HbA1c",
                    "timeFrame": "12 and 48 weeks"
                },
                {
                    "measure": "Effect on pharmacokinetics as assessed by serum concentration-time profiles",
                    "timeFrame": "Day 1 to 48 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Histologic evidence for improvements in MASH",
                    "timeFrame": "48 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or Female, 18 to 70 years of age\n* With MASLD or confirmed diagnosis of MASH based on MRI PDFF \u226510% AND 1 of the following:\n\n  1. Biopsy proven MASH obtained during Screening which confirms the presence of MASH characterized by a NAS \u22654 with at least 1 in each component (steatosis, ballooning, and lobular inflammation) and fibrosis stage F1 to F3. A historical biopsy obtained within 6 months may be acceptable OR\n  2. Meets at least 2 additional metabolic syndrome factors\n* Participants with a BMI \u226525 kg/m2, with stable body weight by history for 3 months\n* Participants must have a waist circumference \u226535 inches (females), or \u226540 inches (males), and must have a waist circumference \u226457 inches (both males and females)\n* Female participants must be non-pregnant, non-lactating or post-menopausal\n* Participants must have the ability and willingness to comply with all Protocol procedures, provide written informed consent and meet all inclusion criteria as outlined in the study protocol\n\nExclusion Criteria: Participants who have:\n\n* A history of active or chronic liver disease\n* Liver cirrhosis (fibrosis stage F4), any prior history of hepatic decompensation, including low platelet counts, esophageal varices, ascites, hepatic encephalopathy, splenomegaly, any hospitalization for treatment of chronic liver disease, or a Model for End Stage Liver Disease score of \u226512\n* Recent (within 3 months of Screening) use of therapies associated with development of MASLD/MASH (eg, systemic corticosteroids, methotrexate, tamoxifen, aromatase inhibitors, amiodarone, or long-term use of tetracyclines)\n* Previous surgical treatment for obesity as well as clinically significant GI disorders\n* Type 1 diabetes mellitus, or T2DM on insulin and/or GLP-1 receptor agonist therapy, dipeptidyl peptidase-4 inhibitors, or other therapies\n* Uncontrolled hypertension or uncontrolled dyslipidemia\n* Participated in an investigational study within 30 days prior to dosing or who have participated in another MASLD/MASH interventional study within 60 days prior to Screening\n* With a history or current diagnosis of acute or chronic pancreatitis or factors for pancreatitis, symptomatic cholelithiasis and/or choledocholithiasis, or alcohol abuse\n* With a history of any major surgery within 3 months prior to Screening\n* With heart failure (New York Heart Association Class III or IV) or any cardiovascular event or evidence of active cardiovascular disease\n* With a presence of clinically significant 12-lead ECG findings at Screening, or cardiac arrhythmia requiring medical or surgical treatment within 6 months prior to Screening\n* With personal or family history of medullary thyroid carcinoma (MTC)\n* With a history of renal disease\n* With a history of alcohol or illicit drug abuse\n* A positive test for hepatitis B surface antigen, hepatitis C RNA, or HIV type 1 or type 2 antibody\n* A clinically significant physical examination, ECG, or laboratory finding, as judged by the Investigator, may interfere with any aspect of study conduct or interpretation of results\n* Not met any other exclusion criteria as outlined in the study protocol",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Senior Director",
                    "role": "CONTACT",
                    "phone": "240-937-5880",
                    "email": "clinicalstudies@neuralymed.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dennis To",
                    "affiliation": "Neuraly, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Summit Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Maitland",
                    "state": "Florida",
                    "zip": "92751",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 28.62778,
                        "lon": -81.36312
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Monroe",
                    "state": "Louisiana",
                    "zip": "71201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.50931,
                        "lon": -92.1193
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "West Monroe",
                    "state": "Louisiana",
                    "zip": "71291",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.51848,
                        "lon": -92.14764
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64131",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43235",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78757",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Bellaire",
                    "state": "Texas",
                    "zip": "77401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.70579,
                        "lon": -95.45883
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Brownsville",
                    "state": "Texas",
                    "zip": "78520",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.90175,
                        "lon": -97.49748
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Corpus Christi",
                    "state": "Texas",
                    "zip": "78404",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.80058,
                        "lon": -97.39638
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Edinburg",
                    "state": "Texas",
                    "zip": "78539",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.30174,
                        "lon": -98.16334
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "Georgetown",
                    "state": "Texas",
                    "zip": "78626",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.63269,
                        "lon": -97.67723
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78222",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Summit Research Site",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000050177",
                    "term": "Overweight"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8375",
                    "name": "Fatty Liver",
                    "relevance": "LOW"
                },
                {
                    "id": "M30540",
                    "name": "Non-alcoholic Fatty Liver Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "relevance": "LOW"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "asFound": "Overweight",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "T5868",
                    "name": "Visceral Steatosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                }
            ]
        }
    },
    "hasResults": false
}